NCT00064064View on ClinicalTrials.gov

3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2003

Study Completion Date

August 31, 2008

Conditions
Lung Cancer
Interventions
DRUG

gemcitabine hydrochloride

DRUG

triapine

Trial Locations (5)

37203

Sarah Cannon Cancer Center at Centennial Medical Center, Nashville

55455

University of Minnesota Cancer Center, Minneapolis

60637-1470

University of Chicago Cancer Research Center, Chicago

77030-4009

University of Texas - MD Anderson Cancer Center, Houston

NL-6500 HB

University Medical Center Nijmegen, Nijmegen

Sponsors
All Listed Sponsors
lead

Vion Pharmaceuticals

INDUSTRY

NCT00064064 - 3-AP and Gemcitabine in Treating Patients With Metastatic Non-Small Cell Lung Cancer | Biotech Hunter | Biotech Hunter